Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 704Neoplasms 622Prostatic Neoplasms 323Lung Neoplasms 316Colorectal Neoplasms 285Carcinoma, Non-Small-Cell Lung 260Pancreatic Neoplasms 181Carcinoma, Hepatocellular 172Stomach Neoplasms 141Multiple Myeloma 128Ovarian Neoplasms 123Melanoma 119Colonic Neoplasms 114Brain Neoplasms 111Hematologic Neoplasms 107Head and Neck Neoplasms 106Urinary Bladder Neoplasms 104Leukemia, Myeloid, Acute 102Esophageal Neoplasms 101Disease 100Uterine Cervical Neoplasms 91Liver Neoplasms 91Neoplasm Metastasis 90Lymphoma 86Rectal Neoplasms 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 84Endometrial Neoplasms 79Carcinoma, Renal Cell 74Leukemia 65Recurrence 63

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Epidermolysis Bullosa Dystrophica × 1 year × Clear all
NCT05843994 2026-02-03

Artificial Intelligence Patient App for RDEB SCCs

Northwestern University

Active not recruiting
20 enrolled
Dermatologic

Congenital Abnormalities, Carcinoma, Squamous Cell, Epidermolysis Bullosa, Skin Abnormalities, Skin Diseases, Skin Diseases, Vesiculobullous, Skin Diseases, Genetic, Skin Neoplasms, Epidermolysis Bullosa Dystrophica, Genetic Diseases, Inborn

NCT06423573 2025-09-19

FOSteR

Amryt Pharma

Recruiting
580 enrolled

Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Junctional

Data powered by HemOnc (CC BY 4.0) Colophon âš¡